510(k) Report

510(k) · Cleared

Recalled · Class II · 2018

Mrsaselect - Extended Incubation

K081212510(k) TraditionalCleared Jun 13, 200845-day reviewClass II21 CFR 866.1700Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Bio-Rad · JSO Culture Media, Antimicrobial Susceptibility Test, Excluding Mueller Hinton Agar

Cleared on Jun 13, 2008 as substantially equivalent to K070361 (Bio-Rad, 2007) after a 45-day review. Its family tree reaches back 3 generations to 1986. 3 later devices descend from it. It has been recalled once.

Decided
Jun 13, 2008
Review
45 days
Class
Class II
Product code
JSO
Recalls
1
Predicates
1

Its longest line of descent runs back 3 generations to K863821 (1986). 3 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2017: 1 descendant cleared2010: 1 descendant cleared2016: 1 descendant clearedK863821 · Mueller Hinton Agar W/4%Nacl and Oxacillin · Gibco Laboratories Life Technologies, Inc. · 1986 · recalledK042812 · Bblchromagar Mrsa · Becton, Dickinson & CO · 2004K070361 · Mrsaselect · Bio-Rad · 20071990200020102020
  1. Root · 3 generations backK863821 Mueller Hinton Agar W/4%Nacl and OxacillinGibco Laboratories Life Technologies, Inc. · 1986 · Recalled
  2. 2 generations backK042812 Bblchromagar MrsaBecton, Dickinson & CO · 2004
  3. 1 generation backK070361 MrsaselectBio-Rad · 2007
  4. This deviceK081212 Mrsaselect - Extended IncubationBio-Rad · 2008
  5. Descendant · cites it directly · 2 of its ownK100589 Mrsa Select - Skin and Soft Tissue Wound SpecimensBio-Rad · 2010
  6. Descendant · cites it directly · 0 of its ownK171061 MRSASelect IIBio-Rad · 2017 · Recalled
  7. Descendant · 2 generations on · 0 of its ownK151688 chromID MRSAbioMerieux, Inc. · 2016

Most influential descendants

Showing 3 of 3 · See all
  • K100589Mrsa Select - Skin and Soft Tissue Wound SpecimensBio-Rad · 2010 · cites it directly2descendants
  • K171061MRSASelect IIBio-Rad · 2017 · cites it directly0descendants
  • K151688chromID MRSAbioMerieux, Inc. · 2016 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K863821Mueller Hinton Agar W/4%Nacl and OxacillinGibco Laboratories Life Technologies, Inc.19861
−2K042812Bblchromagar MrsaBecton, Dickinson & CO2004—
−1K070361MrsaselectBio-Rad2007—
0 (this device)K081212Mrsaselect - Extended IncubationBio-Rad2008—
+1K100589Mrsa Select - Skin and Soft Tissue Wound SpecimensBio-Rad2010—
+1K171061MRSASelect IIBio-Rad20171
+2K151688chromID MRSAbioMerieux, Inc.2016—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201010
201610
201710
FIG. 1 — Lineage of K081212, 1986–2017Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JSO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K070361Mrsaselect
Summary page 2
…t Culture Media 510(k) Submission Substantially Equivalent Device MRSASelect with extended incubation times is substantially equivalent to MRSASelect (reference 510(k) K070361). Manufacturer: Bio-Rad Product: MRSASelect Bio-Rad MRSASelectT M Bio-Rad MRSASelectT M…
Bio-Rad2007—

What descends from it? (3)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K100589Mrsa Select - Skin and Soft Tissue Wound SpecimensBio-Rad20102
K171061MRSASelect IIBio-Rad20170

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Jun 8, 2018Class IIZ-1742-2019Nonconforming Material/ComponentAbnormal coloration of agar plates and the growth of non-characteristic MRSA colonies.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 22 years and passes through 3 companies; a new generation was cleared every 2.8 years on median.
  • 1 of the 3 ancestors has a recall of any class.
  • Of its descendants, K100589 (Bio-Rad, 2010) has gone furthest, with 2 descendants of its own.

How does its category compare?

All JSO devices

JSO Culture Media, Antimicrobial Susceptibility Test, Excluding Mueller Hinton Agar: FDA decisions, review times, recalls and adverse event reports over 20 years. 2008, this device’s year, is highlighted.

FDA decisions per year · JSO

1in 2019

2007: 12008: 22009: 12010: 52011: 22012: 12016: 32017: 22018: 12019: 1
2007high 5 (2010) · low 0 (2013)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JSO

262in 2016

2010: 326 days median2016: 262 days median
2007high 326 (2010) · low 262 (2016)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JSO

15in 2022

2007: 22009: 42011: 32017: 22020: 12022: 15
2007high 15 (2022) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JSO

513in 2025

2008: 12010: 12011: 12013: 12015: 322016: 172017: 432018: 142019: 92020: 72021: 272022: 82023: 122024: 42025: 513
2007high 513 (2025) · low 0 (2007)2025

MAUDE reports naming product code JSO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—20
20082—01
20091—40
2010532601
20112—31
20121—00
20130—01
20140—00
20150—032
20163262017
20172—243
20181—014
20191—09
20200—17
20210—027
20220—158
20230—012
20240—04
20250—0513
20260—0—

What is it indicated for?

MRSASelect is a selective and differential chromogenic medium for the qualitative detection of nasal colonization of methicillin-resistant Staphylococcus aureus (MRSA) to aid in the prevention and control of MRSA infections in healthcare settings. The test can be performed on anterior nares specimens from patients and healthcare workers to screen for MRSA colonization. MRSASelect is not intended to diagnose MRSA infection nor to guide or monitor treatment of infection. Results are interpreted after 18 - 28 hours incubation.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K081212: Mrsaselect - Extended Incubation.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K081212

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026